Pacira Pharmaceuticals (PCRX)

Add to Watchlists Create an Alert
29.76 +0.68  +2.34%   NASDAQ May 23, 10:31AM BATS Real time Currency in USD

Pacira Pharmaceuticals Free Cash Flow:

-25.91M for Dec. 31, 2012
View Full Chart

Pacira Pharmaceuticals Free Cash Flow Chart

    Pacira Pharmaceuticals Historical Free Cash Flow Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 -25.91M
    Sept. 30, 2012 -17.44M
    June 30, 2012 -24.60M
    March 31, 2012 -20.45M
    Dec. 31, 2011 -10.08M
    Sept. 30, 2011 -10.14M
    June 30, 2011 -12.13M
       
    March 31, 2011 -4.819M
    Dec. 31, 2010 -8.788M
    Sept. 30, 2010 -8.812M
    June 30, 2010 -10.04M
    March 31, 2010 -4.013M
    Dec. 31, 2009
    Sept. 30, 2009 -26.79M

    About Free Cash Flow

    Free cash flow is the amount of cash generated by a business that is available for distribution among its security holders. Security holders include debt holders, equity holders, preferred stock holders, and convertible security holders. Specifically, free cash flow is used to pay dividends, make acquisitions, develop new products, invest in new property, plant and equipment, pay interest expenses, and reduce debt.

    According to many investors, free cash flow is the best indication of a company's ability to generate cash.
    Learn More

    Get data for

    PCRX Free Cash Flow Benchmarks

    Companies
    BioScrip
    Neurocrine Biosciences 1.853M
    Lannett Company 6.744M

    PCRX Free Cash Flow Rankings

    Overall 51st percentile
    3901 of 8006
    Sector 25th percentile
    511 of 686 in Healthcare
    Industry 34th percentile
    36 of 55 in Drug Manufacturers - Major

    PCRX Free Cash Flow Range, Past 5 Years

    Minimum -26.79M Sep 2009
    Maximum -4.013M Mar 2010
    Average -14.15M